A carregar...
Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives
Metastatic colorectal cancer (mCRC) is a prevalent disease for which combination cytotoxic chemotherapy is the mainstay of treatment. With the use of targeted therapy, including anti-angiogenic agents, there have been significant improvements in overall outcome of patients with mCRC. Bevacizumab, a...
Na minha lista:
| Publicado no: | Gastrointest Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5300250/ https://ncbi.nlm.nih.gov/pubmed/28190957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/GICTT.S97740 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|